share_log

TD Cowen Initiates Coverage On Prime Medicine With Buy Rating

Moomoo 24/7 ·  Apr 8 17:19

TD Cowen analyst Joseph Thome initiates coverage on Prime Medicine (NASDAQ:PRME) with a Buy rating.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment